Lv1
18 积分 2025-09-16 加入
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial
4小时前
已完结
Intra-Arterial Tenecteplase After Successful Reperfusion in Large Vessel Occlusion Stroke
4小时前
已完结
Safety and efficacy of GD-11 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
10小时前
已完结
Screening Index for Voice Disorder (SIVD): Development and Validation
6个月前
已完结
皖公网安备34019202002308
